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Abstract
Background: Research is needed to explore the relative benefits of alternative electrode
placements in biventricular and left ventricular pacing for heart failure with left bundle branch
block (LBBB).
Methods: A fast computational model of the left ventricle, running on an ordinary laptop
computer, was created to simulate the spread of electrical activation over the myocardial
surface, together with the resulting electrocardiogram, segmental wall motion, stroke volume,
and ejection fraction in the presence of varying degrees of mitral regurgitation. Arbitrary zones
of scar and blocked electrical conduction could be modeled.
Results: Simulations showed there are both sweet spots and poor spots for left ventricular
electrode placement, sometimes separated by only a few centimeters. In heart failure with LBBB
pacing at poor spots can produce little benefit or even reduced pumping effectiveness. Pacing at
sweet spots can produce up to 35% improvement in ejection fraction. Relatively larger benefit
occurs in dilated hearts, in keeping with the greater disparity between early and late activated
muscle. Sweet spots are typically located on the basal to mid-level, inferolateral wall. Poor
spots are located on or near the interventricular septum. Anteroapical scar with conduction
block causes little shift in locations for optimal pacing. Hearts with increased passive
ventricular compliance and absence of pre-ejection mitral regurgitation exhibit greater
therapeutic gain. The durations and wave shapes of QRS complexes in the electrocardiogram
can help predict optimum electrode placement in real time.
Conclusions: Differences between poor responders and hyper-responders to cardiac
resynchronization therapy can be understood in terms of basic anatomy, physiology, and
pathophysiology. Computational modeling suggests general strategies for optimal electrode
placement. In a given patient heart size, regional pathology, and regional dynamics allow
individual pre-treatment planning to target optimal electrode placement.
Key words: bundle-branch block, heart failure, mapping, mitral regurgitation
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Introduction
Cardiac resynchronization therapy (CRT) involves atrio-leftventricular pacing or atriobiventricular pacing in patients with complete heart block or left bundle branch block (LBBB)1 .
The atrial lead is placed high in the right atrium. The left ventricular lead is placed transvenously
in a tributary of the coronary sinus2 or implanted in an epicardial position at surgery3. In both
left ventricular (LV) pacing and bi-ventricular (Bi-V) pacing ventricular stimulation is achieved
by sensing intrinsic atrial activation signals to trigger AV-synchronous pacing. Bi-ventricular
pacing frequently includes atrial pacing as well as atrial sensing. Left ventricular (LV) pacing is
done using a shortened atrioventricular (AV) delay to pre-excite the left ventricle. The longest
AV delay that still produces full pre-excitation is used. Bi-ventricular pacing is done by
simultaneously activating the LV free wall and right ventricular apex via two ventricular leads.
The target site for the right ventricular electrode is the right ventricular apex. The target site for
the left ventricular electrode is typically the lateral or posterior wall, far from the right
ventricular lead4 in the case of Bi-V pacing.
The rationale for CRT is based on the high (30 to 50 percent) prevalence of intraventricular
conduction delay among patients with heart failure 4. In patients having heart failure and LBBB,
early activated muscle can push on late activated muscle during the isovolumic contraction
phase, stretching the opposing wall and causing paradoxical wall motion that is ineffective in
generating aortic valve opening pressures or forward flow. In this way electrical delay translates
into contractile dysfunction.5 In addition late activation of the bases of the papillary muscles
because of intraventricular conduction delay can lead to pre-ejection mitral regurgitation6, 7.
In this setting CRT can resynchronize lateral and septal wall contraction to improve the function
of the heart as a pump6 . Indeed multiple clinical trials have established that in patients with
severe heart failure (NYHA functional class III or IV, and LVEF <= 0.35) and intraventricular
conduction delay (QRS complex duration > 120 to 150 msec) biventricular pacing increases the
left ventricular ejection fraction, decreases mitral regurgitation, and improves symptoms caused
by heart failure4, 8-11. An appealing aspect of CRT is that these acute hemodynamic benefits are
achieved while reducing myocardial energy consumption12. The result is improved long term
survival13.
There is reasonable agreement that the left ventricular lead should be placed anatomically in a
position close to the site of most delayed electromechanical activation11. Currently,
echocardiography with tissue Doppler imaging can be performed in combination with
electrophysiological measurements to determine the most delayed site of ventricular wall
contraction3, 4, 14. However there are still non-responders, estimated to number between 25% and
30% of patients initially expected to benefit from CRT. Non-response may be due to local
pathology, functional block, or less than optimal electrode placement5. Interestingly, there are
also patients treated with CRT that have a “complete” recovery and have been labeled “hyperresponders” (about 13% of cases) who are usually patients with non-ischemic dilated
cardiomyopathy15. This paper is dedicated to the proposition 16 that optimal electrode placement
may further increase response probability over that achieved in current practice, decreasing the
proportion of non-responders and improving overall success.
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Short-term studies have suggested the lateral wall, midway between base and apex3, as a
reasonable target zone for left ventricular lead placement. Ariga and coworkers showed that
greater three-dimensional ventricular lead tip separation is associated with improved outcome
after cardiac resynchronization therapy17. However, recent echocardiographic studies suggest
that in a substantial proportion of patients the anatomically selected pacing site does not always
coincide with ventricular regions having large mechanical delay11, 18. Singh et al.19 in a study of
left ventricular lead position and clinical outcome (MADIT-CRT) found that leads positioned in
the apical region were associated with an unfavorable outcome. Intuitively, myocardial fibrosis
and heterogeneously dispersed scar and/or ischemia might easily modify how electrical delay
translates into contractile dysfunction5.
Accordingly, the objective of the present study was to create a computational model to help
explain and predict (1) the linkage between electrical delay and decline in the function of the
heart as a pump, (2) the roles heart failure, LBBB, pre-ejection mitral regurgitation, and patchy
regional pathology in augmenting functional decline, and (3) the role of electrode placement in
the efficacy of CRT. The aims were to refine general rules appropriate for most hearts and also
to explore approaches for individualized treatment planning, incorporating available information
such as on heart size, local pathology, 3D vector electrocardiography, and ultrasonic Doppler
measurements of wall motion.

Methods
To study the relative benefits of alternative electrode placements in CRT a computer-based
mathematical model of the left ventricle was created describing the spread of electrical activation
over the myocardial surface and the resulting electrocardiogram, segmental wall motion, stroke
volume, and ejection fraction. The model was implemented in Microsoft Visual Basic code
within an Excel spreadsheet on an ordinary laptop computer and validated against known
algebraic solutions for geometric shapes, electrocardiographic potentials in simple test cases, and
expected regional wall motion in pathological cases.
Geometry
The left ventricular endocardium is modeled as a radially symmetrical, roughly bullet shaped
surface, covered with a uniformly thick layer of cardiac muscle. The radius in the base-to-apex
direction can be specified arbitrarily to model any degree of ventricular hypertrophy and
dilatation. The muscle is capable of shortening proportionally in both radial and axial
dimensions, in keeping with the generally helical wrapping of muscle fibers in a living heart20, 21.
The muscle layer is divided into parallel slices perpendicular to the long axis of the left ventricle,
as shown in Figure 1. Each slice has initial thickness, h, and is divided into a specified number
of wedge shaped segments in the circumferential or hoop direction. The standard model has 6
slices of 12 segments each. For initial simulations the radial profile of the endocardial surface
was a parabolic curve fit to a hand-drawn rendition of a typical left ventriculogram in diastole.
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Figure 1. Exploded diagram of component longitudinal slices of the left ventricle.
Radius r1 of the first segment is shown.
Activation sequence
Propagation
Activation of the muscle in each segment occurs either by pacing at specified locations or by
conduction from adjacent muscle at a constant conduction velocity (nominally 60 cm/sec22, 23).
The activation sequence is described by a set of activation times, ij , for each segment at radial
position, i, and axial position, j, in the model. The center of each segment is called a node. Time
zero indicates the onset of electrical ventricular stimulation in a cardiac cycle. To model LBBB
time, ij , is set to zero for right anterolateral segments in contact with distal fibers of the right
bundle branch. For segments in contact with pacing electrodes, the time, ij , represents the onset
of pacing. For other segments activated by cell to cell conduction, the time, ij , represents the
time of arrival of the activation wave front at node (i, j).
The algorithm for tracking propagation of the wave of activation through the myocardium is as
follows. Let k be an indexed node, and let n be a neighboring node in either the axial,
diagonal, or radial direction. Let t be clock time, and let n be the activation time of
neighboring node, n. If node k is viable (not scar) but not yet active, and if node n is active,
and if t - n equals the impulse travel time between nodes k and n, then k becomes active with
k = t. In this way the arrival of the activation wave front can be mapped as it spreads across the
myocardium in terms of arrival times, ij, for all nodes (i, j) in the model.
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Activation display
To show a three dimensional movie of ventricular activation, an x,y,z coordinate system is
defined for the chest with its origin at the base of the heart, the x-axis pointing to the left axilla,
the y-axis pointing toward the feet, and the z-axis pointing anteriorly toward the sternum. Axial
and radial coordinates for left ventricular nodes are computed and overlaid with the y-axis of the
model. Then the axis of the left ventricle is rotated 30 degrees to the left and 30 degrees
anteriorly to a more anatomically realistic orientation, using standard formulas for rotation of
axes24 . Locations of the endocardial nodes during activation are logged in this rotated x,y,z
coordinate system. To create a movie of the activation sequence in time, t, ranging from 0 to
tmax (when the last viable node is stimulated) all active nodes are displayed graphically in a
frontal (x, y) projection every 1/40 th second of simulation time.
Dynamics
Active segments
Once the activation sequence and the set of times (i, j) have been computed and saved in
memory, ventricular wall dynamics are found as follows. Left ventricular intracavitary volume
is divided into wedge-shaped sections of local radius rij and local thickness hij, corresponding
to each node of the model. After onset of activation these dimensions undergo shortening,
representing cardiac muscle contraction. Muscle contraction lasts 40 percent of cycle time and
has a half-sinusoidal waveform. In particular, the linear dimensions, r and h, are multiplied by
a shortening factor ij (t )  1  max (0,  max sin(2 (5 / 4)f (t  ij ))) . Each local shortening factor
ij(t)  1, has a half-sinusoidal waveform during systole and a constant value of 1 during diastole.
The variable max is the maximal shortening fraction for individual cardiomyocytes, and f is the
pacing frequency in Hz. The duration of the positive half sinusoidal phase of function (t) is
40% of cycle time. For a normal ejection fraction of 60%, the maximal shortening, max, would
be
1 – (0.4)1/3 = 0.26, using classical scaling rules25, 26.
Assuming each local intracavitary segment retains a wedge shape during systole that is
geometrically similar to that in diastole, and using well-known scaling rules25, 26 for similarly
shaped objects, the local intracavitary volume at node (i, j) changes instantaneously as a function
of time by a factor of ij(t)3. Thus the sum of all volumes swept out by active muscle segments,
V1(t), can be calculated easily for dynamic simulation time, t, ranging from 0 to tmax (the end of
ejection, when left ventricular volume is minimal).
Passive segments
Before opening of the aortic valve, the volume that is swept out by contraction of active
segments distends the remaining passive segments. Let V2 represent the instantaneous
intracavitary volume underlying non-contracting muscle, scarred areas, and the mitral valve.
The volumes underlying these passive surfaces are expanded by a factor of
5

V1 ( t ) / V2 ( t )  ( 2 ( t ))3 , where 2(t) is the extension ratio for the radius and height of the
stretched, passive segments. For simplicity, the value of 2(t) is the same (an average value) for
all passive segments. Thus before aortic valve opening, the remaining passive segments are
stretched by factor of 2(t) = (V1 / V2 )1/ 3 After aortic valve opening the amount of passive
stretch of inactive or scarred segments is considered constant in time during ejection, as the left
ventricle empties.

Left ventricular pressure
Left ventricular pressure before ejection is computed from the volume swept out by active
muscle and the compliance of the remaining passive segments plus the compliance of the mitral
valve in closed position. For initial end diastolic volume, V0 , of the left ventricle at time zero,
the compliance of residual passive muscle and mitral valve together would be

Cp (t ) 

V2 ( t )
V1 ( t )
,
C pLV 
V0
P( t )

for instantaneous pressure rise, P(t), in the left ventricle and passive compliance of the whole
left ventricle with the mitral valve closed, CpLV, which is a given model parameter. If the
opening pressure in the aortic valve is Po  80 mmHg, then stretching of passive segments
occurs either until the segments are activated and begin to contract or until

P( t ) 

V0 V1 ( t )
 Po  80 mmHg
C pLV V2 ( t )

and the aortic valve opens, venting the left ventricular volume.
Left ventricular volume
Left ventricular volume is computed as the sum of all intracavitary volume wedges having local
dimensions rij and hij. Stroke volume is computed as the difference between initial diastolic
volume, V0, and the minimum instantaneous left ventricular volume, minus any backward leaks
through the mitral valve caused by papillary muscle dysfunction or frank mitral regurgitation.
Papillary muscle dysfunction and mitral regurgitation
Function of the papillary muscles and their dysfunction in complete heart block and left bundle
branch block are modeled as follows. A fraction (ranging from zero to 40 percent) of the volume
swept out by actively contracting muscle is allowed to leak from the left ventricular cavity until
such time as the specified locations of the bases of the both the anterolateral and posteromedial
papillary muscles are activated. This volume of retrograde leak is subtracted from the difference
in end diastolic and end systolic intracavitary volumes to obtain forward stroke volume. In
initial models mitral regurgitation was zero.

6

Regional pathology
Numerical entries in a table of all nodes are used to indicate areas of local scar or dysfunctional
tissue. Both local impulse propagation velocity and local muscle contraction were set to zero in
scared areas. Alternatively, slowed conduction or hypocontraction could be programmed, if
desired.
Segmental wall motion
To show a three dimensional movie of ventricular wall dynamics in some simulations, the spatial
locations of all endocardial nodes during activation and ejection were logged in the realistically
rotated x,y,z coordinate system and the frontal (x, y) and lateral (y, z) projections displayed
graphically to create movies of a wire frame model of the endocardium, similar to a left
ventriculogram.
Simulation of the electrocardiogram
Coordinates, x,y,z, for the location of a typical “left arm” electrode were selected. To simulate
the signal in lead aVL the summed dipole potential at this point, U   u ij , from all pairs of
nodes in the model representing boundaries between active and passive muscle was computed
versus the Wilson central terminal using the formula developed by Babbs27 ,

u ij  3.5

A ij cos ij
R ij2

millivolts

for area, Aij, of propagating wave front between nodes in either the axial or radial directions with
left ventricular wall thickness equal to 1.5 cm from endocardium to epicardium; angle, ij,
between the axis of propagation and the line from the center of each dipole to the left arm
electrode; and distance, Rij, between the center of each dipole and the left arm electrode. As
excitation spread outward from pacing sites around the myocardium in LBBB, the summed
electrical potential, U, traced a simulated wide QRS complex based upon the array of electrical
dipoles created at the interfaces between depolarized (contracting) and polarized (resting) muscle
tissue27. Simulated scar tissue did not contribute to electrical potentials.
Parameter values
Required numerical values for a standard, normal sized heart model are summarized in Table 1.
The standard model included 72 nodes (12 radial x 6 axial) representing the left ventricular
endocardium and overlying muscle. Spread of the wave front of activation was computed every
0.2 msec. The heart rate was 80 beats per minute and the duration of systole was 40 percent of
cycle time. Passive left ventricular compliance was estimated as ~ 1 ml/mmHg by dividing
typical normal values for left atrial pressure rise and left ventricular volume increase during atrial
contraction in sinus rhythm.

7

TABLE 1. Parameter Values for Primary Model.*

Parameter
Base to apex dimension
Maximal LV radius
Number of nodes in hoop dimensions
Number of nodes in axial dimension
Muscle to muscle impulse conduction velocity
Passive LV compliance
Fraction of LV volume underlying non-muscle tissue
Heart rate
Diastolic arterial pressure
LV axis with respect to vertical and horizontal

Numerical
value
9
2.7
12
6
60
1
0.15
80
80
30

Units
cm
cm

cm/sec
ml/mmHg
1/min
mmHg
degrees

* LV denotes left ventricle; normal heart size (scale = 1.0)

In the primary model for a normal sized heart the radius, r, in centimeters was defined as
r = 2 + 0.65n – 0.15n2 for node number, n, in the axial dimension, measured from the base of the
heart toward the apex. Thus, the internal radii of the six transverse slices of left ventricular
myocardium were 2.5, 2.7, 2.6, 2.2, 1.5, and 0.5 cm, respectively. In the primary model for a
dilated heart the linear dimensions of the internal radii and the axial slice separation, h, were
multiplied by a factor of 1.5. In turn, end diastolic volume increased from 130 to 440 ml. The
base of the anterolateral papillary muscle was located approximately 54 degrees to the left of
anterior and 60 percent of the distance from base to apex. The base of the posteromedial
papillary muscle was located approximately 144 degrees to the right of anterior and 50 percent of
the distance from base to apex.
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Heart failure with left bundle branch block
Left bundle branch block with left ventricular pacing was simulated in two models of heart
failure. The first had uniform reduction in muscle contraction throughout the left ventricle
(nonischemic cardiomyopathy). The second had an anteroapical region of scar tissue that did not
conduct or contract in the territory of the left anterior descending coronary artery (old apical
infarct in the setting of ischemic heart disease).
Heart failure was simulated by adjusting maximal fiber shortening, e max, of normal muscle so
that ejection fraction was < 35%, representing patients who would be legitimate candidates for
bi-ventricular pacing. The maximal linear shortening of muscle fibers in the normal sized heart
model was 0.15, creating a control stroke volume of 33 ml and an ejection fraction of 25%. The
maximal linear shortening of muscle fibers in the 1.5x dilated heart model was 0.075, creating a
control stroke volume of 47 ml and an ejection fraction of 11%.
Ventricular beats with LBBB were initiated along the apical half of the meridian stretching from
the right ventricular apex to the interventricular septum, at an angle approximately 45 degrees
counterclockwise from the vertical (anterior) position on the left ventricular profile. This
location corresponds to the branched distal half of the right bundle branch, which would
stimulate the interventricular septum to produce a pattern of ventricular breakthrough and
activation similar to that reported in the literature23, 28. After time zero, activation spreads
outward by cell to cell conduction.
Left ventricular versus bi-ventricular pacing
To simulate the LV pacing mode with pre-excitation of the left ventricle the site of the left
ventricular electrode is activated at time zero. Subsequent excitation of the interventricular
septum by the intact right bundle branch block is modeled the same way as in untreated LBBB,
beginning after a delay of 50 msec. This delay represents the difference between the normal AV
conduction time (150 msec) and the programmed pre-excitation delay (100 msec). To simulate
biventricular pacing, both the left ventricular pacing site and a right ventricular apical pacing site
are activated simultaneously at time zero. Thus in both modes time zero represents the earliest
onset of ventricular excitation. (Atrial pacing and pumping are not included for simplicity.)
Unless otherwise specified, the location of the right ventricular electrode for Bi-V pacing was on
the anterolateral interventricular septum, 75% of the distance from base to apex.

Results
Simulated biventricular and left ventricular pacing in heart failure with LBBB
The figure of merit to assess the benefit or harm of CRT was the percentage change in stroke
volume, compared with native LBBB, caused by left ventricular pacing at any specified location.
Figure 2 shows endocardial maps of the percentage change in stroke volume obtained when biventricular pacing was initiated at any particular LV site together with an electrode at the right
ventricular apex. The perspective shown is that obtained by opening the left ventricle by an
9

anterior longitudinal incision from base to apex (about 1 cm left of the left anterior descending
coronary artery) and separating the halves of the left ventricle laterally in a clamshell
configuration. The base of the heart is shown toward the top and the apex toward the bottom.
The interventricular septum is anatomically on the right (left hand side of the drawing). The left
ventricular free wall is anatomically on the left (right hand side of the drawing), and the posterior
ventricular wall is in the middle.

30 to 40
20 to 30
10 to 20
0 to 10
–10 to 0

Figure 2. Percentage changes in stroke volume with bi-ventricular pacing at various
locations mapped onto the surface of the left ventricular endocardium in models of
heart failure plus LBBB. Map indicates sites of the left ventricular electrode. Normal
sized heart on top; 1.5x enlarged heart on bottom. Solid dot indicates optimum
placement.
Stroke volume is diminished by bi-ventricular pacing in the region of the mid-interventricular
septum, causing a negative change. Stroke volume is augmented by bi-ventricular pacing in the
basilar region of the posterolateral wall, causing a positive change. There are both sweet spots
and sour spots for biventricular pacing. The magnitudes of the changes range from –1% to 17%
in normal sized hearts (above) and from –3% to 24% in dilated hearts. As expected, simulated
cineangiograms of LBBB (not shown) indicate paradoxical budging in late-activated muscle. Biventricular pacing near this late activated site produces the greatest improvement in stroke
volume. Black dots indicate pacing sites for maximal gain in stroke volume. Cross-hatched
shading indicates larger target zones for electrode placement with similarly positive
hemodynamic benefit. Such nearly optimal regions for left ventricular electrode placement may
be practically achievable.
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Figure 3 shows endocardial maps obtained when left-ventricular pacing was initiated in models
of heart failure with LBBB assuming a 100 msec AV delay and a 150 msec natural AV
conduction time. Hence the LV pacing site was activated by LV pacing 50 msec before the right
anteroapical interventricular septum was activated by the intact right bundle branch. The
positive effects of pacing of the left ventricular free wall are similar to those in bi-ventricular
pacing. The relative improvement of stroke volume ranged from –8% to 19% in normal sized
hearts and from –5% to 35% in enlarged hearts. Optimal LV pacing sites are somewhat closer to
the cardiac apex than in bi-ventricular pacing. Pacing of the interventricular septum or adjacent
regions produces little or no benefit and occasionally some harm.

30 to 40
20 to 30
10 to 20
0 to 10
–10 to 0

Figure 3. Percentage changes in stroke volume at various locations with leftventricular pacing and pre-excitation of the left ventricle 50 msec before activation of
anteroapical muscle by the native right bundle. Other details similar to Figure 2.

Right ventricular electrode placement
The benefit of Bi-V pacing depends on the position of the right ventricular pacing electrode as
well as the left ventricular electrode. In Figure 2 the RV electrode was located at a position
along the interventricular septum corresponding to the latitude of the right ventricular apex, three
quarters of the distance from the left ventricular base to the left ventricular apex. Other locations
for the septal electrode are shown in Figure 4 in terms of the percentage distance from base to
apex along the septum, including one extreme apical position that would require epicardial rather
than transvenous electrode placement. Left ventricular electrode placement was constant at a
position corresponding to the optimal location in Figure 2 (posterolateral base). The dashed line
indicates the improvement in ejection fraction with LV pacing. The dotted line indicates the
11

improvement in ejection fraction of with an idealized Purkinje system that achieves simultaneous
activation of all ventricular muscle at time zero.
There are only modest differences in acute hemodynamic effectiveness between LV and Bi-V
pacing when the right ventricular electrode pacing electrode is located near the mid portion of
the interventricular septum. A modest improvement over the right ventricular apical position
may be possible with electrode positions higher up on the septal wall.

Figure 4. Percentage changes in ejection fraction for bi-ventricular pacing with
variable positions of the septal electrode in models of heart failure with LBBB. Left
ventricular electrode position was constant at node location 8,1. Normal sized heart on
left, dilated heart on right. Note differences in the vertical scales.

Passive left ventricular compliance
In keeping with the mechanistic hypothesis that paradoxical bulging of late activated muscle is
the root cause of stroke volume loss in heart failure with LBBB, the author explored effects of
varying passive LV compliance. Figure 5 shows the dependence of stroke volume on passive
ventricular compliance of with native LBBB and during electrode position optimized Bi-V
pacing on for the normal sized and dilated heart models. Increased passive compliance worsens
stroke volume with native LBBB and allows for relatively greater therapeutic gain from Bi-V
pacing.
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Figure 5. Computed stroke volumes for heart failure and native LBBB versus biventricular pacing with variable passive left ventricular compliance.

Pre-ejection mitral regurgitation
Figure 6 shows the benefits of electrode position optimized Bi-V pacing in patients with varying
degrees of pre-ejection mitral regurgitation. In these models a varying fraction, shown on the
horizontal axis, of the volume swept out by contracting muscle flowed retrograde until 10 msec
after the bases of both anterior and posterior papillary muscles in the left ventricle were
activated. These models recreated varying degrees of LBBB induced pre-ejection papillary
muscle dysfunction. Increasing pre-ejection mitral regurgitation degrades the therapeutic gain
of bi-ventricular pacing.
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Figure 6. Computed percentage improvement in stroke volume for bi-ventricular
pacing with optimized LV electrode placement and variable degrees of early preejection mitral regurgitation.

Simulated biventricular pacing in heart failure, LBBB, and local apical pathology
The effects of anteroapical scar were simulated by blocking impulse activation, impulse
conduction, and muscle contraction in the scarred region. Scarred tissue had passive compliance
properties. These simulations represented extreme local pathology located in the distribution of
the left anterior descending coronary artery. Maps of hemodynamic effectiveness vs. LV
electrode placement like those in Figure 2 were constructed for the local scar models.
Percentage changes in ejection fraction were similar to non-scarred models, ranging from –5% to
13% for the normal sized heart model (compared with–1% to 17% in models without regional
pathology) and from –17% to 21% in scarred and dilated heart models (compared with –3% to
24% in models without regional pathology). Local pathology slightly increases the downside
and reduces the upside of CRT. There are also small shifts in the positions of optimal LV
electrode placements toward the sites of scar (Figure 7). Importantly, local pathology appears to
increase the sizes of zones associated with negative hemodynamic benefit.
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Figure 7. Percentage changes in stroke volume with bi-ventricular pacing at various
locations mapped onto the surface of the left ventricular endocardium in models of
heart failure, LBBB, and scared anteroapical ventricular muscle. Other details similar
to Figure 2.

Simulated electrocardiographic waveforms as guides to electrode placement
Figure 8 shows the simulated electrocardiographic waveforms of QRS complexes in Lead aVL
for native LBBB (curve 1, dotted line) and for optimal biventricular pacing (curve 2, solid line)
in the model of complete heart block. Optimal biventricular pacing shortens the duration and
reduces the voltage of the paced QRS complex, producing a characteristic low-amplitude,
“isoelectric” waveform pattern in Lead aVL.
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Figure 8. Simulated QRS complexes in lead aVL for model of heart failure plus
LBBB. Curve 1 represents native LBBB. Curve 2 represents bi-ventricular pacing at
the optimal posterolateral electrode location. Pacing spikes are not shown. Voltage
scales are in millivolts. Time scales are in seconds.

Discussion
Location of the left ventricular pacing electrode is critical for hemodynamic benefit in CRT.
There are sweet spots that substantially improve pumping and also sour spots that may actually
reduce forward flow. In between there are regions of little therapeutic benefit. Previous authors
have described poor responders and hyper-responders15 to CRT. The importance of placing the
second pacing electrode far from the first has also been recognized 17 . This modeling study
extends and confirms these empirical findings and shows that they can be understood in terms of
basic anatomy and physiology. In the absence of a working Purkinje system, dual pacing sites
on opposite sides of the left ventricle allow for more nearly simultaneous activation, providing a
first level of validation of the model based on available published data.
Mathematical models can help explain and predict the variable results of CRT and can aid in
treatment planning. The models presented here can be readily expanded to include arbitrarily
shaped geographic areas of scar tissue or ischemia with variably decreased cell to cell conduction
velocity and local contractile shortening. Using available clinical data suggesting the type and
location of myocardial pathology, heart size, and diastolic blood pressure, and the presence of
any mitral regurgitation, one can create patient individualized models for treatment planning that
16

predict not only the zones of maximal benefit, but also the morphology of paced QRS complexes
in any electrocardiographic lead. These might well be used to help identify proper electrode
placement in real time, since the paced QRS waveform and duration may give an immediate
indication, during the implant procedure, of effectiveness in any given patient. In this way
model-based treatment planning could be a significant aid to navigation in this tricky clinical
environment.
Results generated by the present computational models are consistent with earlier clinical
observations in terms of the predicted patterns of activation, the predicted reduction in QRS
complex duration, and the predicted improvement in pumping effectiveness.
Patterns of activation and contraction
The sequences of electrical activation and the patterns of wall motion predicted by the model are
realistic and similar to those described by Auricchio and Abraham29 and by Fung and Berger et
al.23, 28 Activation travels essentially in circumferential directions, justifying the one layer
muscle model. As expected, left bundle branch block results in delayed depolarization and
contraction of the left ventricular free wall, accompanied by early paradoxical bulging.
QRS duration reduction
Changes in QRS duration produced by CRT, as predicted by the model, are also in reasonable
agreement with published studies, which found mean reductions in QRS complex duration from
182 to 143 msec3, 174 to 157 msec4, and 190 to 165 msec30. Simulations of Figure 8 show
comparable reductions in QRS durations.
Improved pumping
The present computational models predict the improvements in the function of the heart as a
pump produced by CRT with posterolateral free wall placement of the left ventricular pacing
electrode in the range of –10 to +35 percent. Clinical studies show similar results in terms of
mean values in small series of patients: 16%31 and 18%32 improvement in pulse pressure, 12%
improvement in ejection fraction7, and 48% increase in ejection fraction at 1 year follow up.33
(Note in comparing one year follow up data, the present model does not include late effects such
as reverse remodeling or improved myocardial metabolism associated with earlier relaxation and
longer perfusion time, however, the model does include redistribution of regional ventricular
loading, and reduction or abolition of mitral regurgitation.) The calculated rough equivalence of
acute hemodynamic benefits of LV and Bi-V pacing agrees with the rough equivalence of long
term benefit reported by Thibault and coworkers34. Modeling predicts a range of potential
benefit within the general posterolateral wall area, offering the promise of better results with
better targeting of electrode placement. However, non-response remains a distinct possibility
with poor electrode placement and smaller heart size.
The present modeling approach is limited to the effects of defined inputs. The intent is to
capture the essence of underlying mechanisms with reasonable mathematical simplicity.
However, it is quite possible that unmodeled variables or confounders might be present in some
17

patients that would influence results. For example, the present model includes only a single
layer of cardiac muscle, rather than multiple layers from endocardium to epicardium. Multiple
layers of myocardium, which can be added to the model at the cost of some complexity and
increased computation time, might make a biologically meaningful difference in cases of left
ventricular hypertrophy, much more than in cases of dilated cardiomyopathy where the wall
thickness dimension is less prominent. Also, the present model is intended to predict acute
hemodynamic gain only and does not reflect effects of tissue remodeling. As such it might
underestimate the long term benefits of CRT.

Conclusions
The present simple and easily implemented computational models can inform targeting of left
ventricular electrode placement in a general way and even allow for patient individualized
treatment planning in the presence of variable left ventricular activation patterns28 and
pathologies. Identifying a particular patient’s sweet spot in a process of computer aided
individual treatment planning should be possible using models that receive multi-modal input
regarding the size and local pathology of a particular heart, including regional wall motion by
echocardiography35, 36. Such methods for better definition of optimal electrode placement may
guide clinicians using the transvenous approach or perhaps suggest alternative open surgical 3 or
percutaneous transapical approaches37, if coronary sinus and cardiac vein anatomy are
unfavorable for transvenous techniques.
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